Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SEC. AND CHIEF LEGAL OFFICER

EXECUTIVE CHAIRMAN

CHIEF FINANCIAL OFFICER

CEO AND PRESIDENT

PRESIDENT, CLINICALDIAGNOSTICS

PRESIDENT, CHIEF BUS. OFFICER

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company's products also comprise Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-10	Premium	sold	Premium	Premium	Premium	SEC. AND CHIEF LEGAL OFFICER
2024-05-10	Premium	sold	Premium	Premium	Premium	-
2024-05-10	Premium	acquired	Premium	Premium	Premium	SEC. AND CHIEF LEGAL OFFICER
2024-05-08	Premium	acquired	Premium	Premium	Premium	EXECUTIVE CHAIRMAN
2024-05-01	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-29	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-29	Premium	sold	Premium	Premium	Premium	CEO AND PRESIDENT
2024-04-29	Premium	sold	Premium	Premium	Premium	PRESIDENT, CLINICALDIAGNOSTICS
2024-04-29	Premium	sold	Premium	Premium	Premium	PRESIDENT, CHIEF BUS. OFFICER
2024-04-29	Premium	sold	Premium	Premium	Premium	SEC. AND CHIEF LEGAL OFFICER
2024-04-26	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-26	Premium	acquired	Premium	Premium	Premium	-
2024-04-25	Premium	sold	Premium	Premium	Premium	-
2024-04-25	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-24	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-04-23	Premium	sold	Premium	Premium	Premium	PRESIDENT, CHIEF BUS. OFFICER
2024-04-23	Premium	sold	Premium	Premium	Premium	SEC. AND CHIEF LEGAL OFFICER

NTRA - Natera Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for NTRA